{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:33:31Z","timestamp":1793763211200,"version":"4.6.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,24]],"date-time":"2014-12-24T00:00:00Z","timestamp":1419379200000},"content-version":"vor","delay-in-days":388,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jacc.2013.10.028","type":"journal-article","created":{"date-parts":[[2013,12,16]],"date-time":"2013-12-16T21:21:34Z","timestamp":1387228894000},"page":"D117-D126","source":"Crossref","is-referenced-by-count":383,"special_numbering":"S","title":["Pediatric Pulmonary Hypertension"],"prefix":"10.1016","volume":"62","author":[{"given":"D. Dunbar","family":"Ivy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Abman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn J.","family":"Barst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf M.F.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila G.","family":"Haworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Usha","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika B.","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingram","family":"Schulze Neick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin H.","family":"Steinhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Beghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2013.10.028_bib1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/hrt.2008.150086","article-title":"Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001\u20132006","volume":"95","author":"Haworth","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2013.10.028_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.acvd.2009.12.001","article-title":"Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in France","volume":"103","author":"Fraisse","year":"2010","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2013.10.028_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCULATIONAHA.111.026591","article-title":"Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management","volume":"125","author":"Barst","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.10.028_bib4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(11)61621-8","article-title":"Clinical features of paediatric pulmonary hypertension: a registry study","volume":"379","author":"Berger","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2013.10.028_bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1183\/09031936.00056110","article-title":"Pulmonary arterial hypertension: a comparison between children and adults","volume":"37","author":"Barst","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2013.10.028_bib6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D\u2019Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2013.10.028_bib7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0735-1097(98)00668-8","article-title":"Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing","volume":"33","author":"Atz","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/01.CIR.103.4.544","article-title":"Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms","volume":"103","author":"Rimensberger","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.10.028_bib9","doi-asserted-by":"crossref","first-page":"I76","DOI":"10.1161\/01.cir.0000032875.55215.cb","article-title":"Inhaled nitric oxide as a preoperative test (INOP test I): the INOP Test Study Group","volume":"106","author":"Balzer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.10.028_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2007.09.031","article-title":"Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension","volume":"51","author":"Ivy","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib11","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s00246-012-0597-9","article-title":"Acute pulmonary vasodilator testing with inhaled treprostinil in children with pulmonary arterial hypertension","volume":"34","author":"Takatsuki","year":"2013","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib12","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/01.CIR.0000138104.83366.E9","article-title":"Outcomes in children with idiopathic pulmonary arterial hypertension","volume":"110","author":"Yung","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.10.028_bib13","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","volume":"111","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.10.028_bib14","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/PCC.0b013e3181d10cce","article-title":"Preoperative pulmonary hemodynamics and assessment of operability: is there a pulmonary vascular resistance that precludes cardiac operation?","volume":"11","author":"Giglia","year":"2010","journal-title":"Pediatric Crit Care Med"},{"key":"10.1016\/j.jacc.2013.10.028_bib15","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/0002-9149(91)90284-R","article-title":"Late results (30 to 35 years) after operative closure of isolated ventricular septal defect from 1954 to 1960","volume":"68","author":"Moller","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib16","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1093\/eurheartj\/ehr282","article-title":"Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria","volume":"32","author":"Douwes","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2013.10.028_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.amjcard.2004.09.006","article-title":"New predictors of outcome in idiopathic pulmonary arterial hypertension","volume":"95","author":"Kawut","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib18","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1161\/CIRCGENETICS.111.961888","article-title":"Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension","volume":"5","author":"Austin","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacc.2013.10.028_bib20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa1211097","article-title":"A\u00a0novel channelopathy in pulmonary arterial hypertension","volume":"369","author":"Ma","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2013.10.028_bib21","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/jmedgenet-2012-101152","article-title":"TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertension","volume":"50","author":"Kerstjens-Frederikse","year":"2013","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.jacc.2013.10.028_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ppedcard.2009.09.006","article-title":"Pulmonary venous hypertension or pulmonary hypertension due to left heart disease","volume":"27","author":"Adatia","year":"2009","journal-title":"Prog Pediatr Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MOP.0b013e328360a3f6","article-title":"Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond","volume":"25","author":"Mourani","year":"2013","journal-title":"Curr Opin Pediatr"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2013.10.028_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1017\/S1047951109003965","article-title":"Pulmonary hypertension associated with congenital diaphragmatic hernia","volume":"19","author":"Thebaud","year":"2009","journal-title":"Cardiol Young"},{"key":"10.1016\/j.jacc.2013.10.028_bib25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/MOP.0b013e328352c4f2","article-title":"Recent advances in the management of congenital diaphragmatic hernia","volume":"24","author":"Rollins","year":"2012","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jacc.2013.10.028_bib26","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4103\/2045-8932.83456","article-title":"A\u00a0consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: report from the PVRI Pediatric Taskforce, Panama 2011","volume":"1","author":"Cerro","year":"2011","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jacc.2013.10.028_bib27","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0022-5223(04)00991-2","article-title":"Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure","volume":"128","author":"Mitchell","year":"2004","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2013.10.028_bib28","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s00246-011-9950-7","article-title":"Connective tissue disease presenting with signs and symptoms of pulmonary hypertension in children","volume":"32","author":"Takatsuki","year":"2011","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib29","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1056\/NEJM198211043071902","article-title":"Pulmonary hypoplasia in Down\u2019s syndrome","volume":"307","author":"Cooney","year":"1982","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2013.10.028_bib30","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00431-010-1361-x","article-title":"Down syndrome patients with pulmonary hypertension have elevated plasma levels of asymmetric dimethylarginine","volume":"170","author":"Cua","year":"2011","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jacc.2013.10.028_bib31","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00431-010-1378-1","article-title":"Management of pulmonary hypertension in Down syndrome","volume":"170","author":"Hawkins","year":"2011","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jacc.2013.10.028_bib32","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1161\/CIRCULATIONAHA.110.969584","article-title":"Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005","volume":"124","author":"van Loon","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.10.028_bib33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1183\/09031936.00114212","article-title":"Do tertiary paediatric hospitals deal with the same spectrum of paediatric pulmonary hypertension as multicentre registries?","volume":"41","author":"Levy","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2013.10.028_bib34","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1136\/hrt.2009.182378","article-title":"Childhood idiopathic pulmonary arterial hypertension: a national cohort study","volume":"96","author":"Moledina","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2013.10.028_bib35","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/0735-1097(94)00391-3","article-title":"Primary pulmonary hypertension in children: clinical characterization and survival","volume":"25","author":"Sandoval","year":"1995","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.amjcard.2010.02.023","article-title":"Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies","volume":"106","author":"van Loon","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib37","article-title":"Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups","author":"Manes","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2013.10.028_bib38","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/adc.2007.120493","article-title":"The management of pulmonary hypertension in children","volume":"93","author":"Haworth","year":"2008","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jacc.2013.10.028_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ppedcard.2009.09.003","article-title":"Pulmonary arterial hypertension in children: diagnostic work up and challenges","volume":"27","author":"Rosenzweig","year":"2009","journal-title":"Prog Pediatr Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib40","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1183\/09031936.00140112","article-title":"Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice","volume":"42","author":"Beghetti","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2013.10.028_bib41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jpeds.2005.02.019","article-title":"Portopulmonary hypertension in pediatric patients","volume":"147","author":"Condino","year":"2005","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jacc.2013.10.028_bib42","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4103\/2045-8932.83445","article-title":"Functional classification of pulmonary hypertension in children: report from the PVRI Pediatric Taskforce, Panama 2011","volume":"1","author":"Lammers","year":"2011","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jacc.2013.10.028_bib43","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.amjcard.2010.06.064","article-title":"Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings","volume":"106","author":"Ivy","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib44","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1378\/chest.08-0187","article-title":"Brain natriuretic peptide levels in managing pediatric patients with pulmonary arterial hypertension","volume":"135","author":"Bernus","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2013.10.028_bib45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijcard.2008.03.009","article-title":"Prognostic value of B-type natriuretic peptide in children with pulmonary hypertension","volume":"135","author":"Lammers","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1203\/PDR.0b013e318163a2e7","article-title":"Biological serum markers in the management of pediatric pulmonary arterial hypertension","volume":"63","author":"Van Albada","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jacc.2013.10.028_bib47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijcard.2008.12.087","article-title":"Heart rate variability predicts outcome in children with pulmonary arterial hypertension","volume":"142","author":"Lammers","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib48","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1213\/01.ane.0000255732.16057.1c","article-title":"Perioperative complications in children with pulmonary hypertension undergoing noncardiac surgery or cardiac catheterization","volume":"104","author":"Carmosino","year":"2007","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jacc.2013.10.028_bib49","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/ccd.22693","article-title":"Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry","volume":"76","author":"Hill","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2013.10.028_bib50","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/bja\/aem059","article-title":"Risk of cardiac catheterization under anaesthesia in children with pulmonary hypertension","volume":"98","author":"Taylor","year":"2007","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jacc.2013.10.028_bib51","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.amjcard.2010.03.048","article-title":"Usefulness of the right ventricular systolic to diastolic duration ratio to predict functional capacity and survival in children with pulmonary arterial hypertension","volume":"106","author":"Alkon","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib52","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ahj.2013.02.027","article-title":"Prognostic significance of 2-dimensional, M-mode, and Doppler echo indices of right ventricular function in children with pulmonary arterial hypertension","volume":"165","author":"Kassem","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2013.10.028_bib53","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.echo.2012.01.017","article-title":"Value of tissue Doppler echocardiography in children with pulmonary hypertension","volume":"25","author":"Lammers","year":"2012","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jacc.2013.10.028_bib54","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jpeds.2012.05.050","article-title":"Tissue Doppler imaging predicts adverse outcome in children with idiopathic pulmonary arterial hypertension","volume":"161","author":"Takatsuki","year":"2012","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jacc.2013.10.028_bib55","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.echo.2009.03.026","article-title":"Right ventricular function in infants, children and adolescents: reference values of the tricuspid annular plane systolic excursion (TAPSE) in 640 healthy patients and calculation of z score values","volume":"22","author":"Koestenberger","year":"2009","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jacc.2013.10.028_bib56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/adc.2009.169904","article-title":"Comparison of 6-min walk test distance and cardiopulmonary exercise test performance in children with pulmonary hypertension","volume":"96","author":"Lammers","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jacc.2013.10.028_bib57","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1378\/chest.08-1658","article-title":"Safety of maximal cardiopulmonary exercise testing in pediatric patients with pulmonary hypertension","volume":"135","author":"Smith","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2013.10.028_bib58","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/CIRCIMAGING.112.000082","article-title":"Prognostic significance of cardiac magnetic resonance imaging in children with pulmonary hypertension","volume":"6","author":"Moledina","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2013.10.028_bib59","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ahj.2007.08.014","article-title":"Pulmonary vascular input impedance is a combined measure of pulmonary vascular resistance and stiffness and predicts clinical outcomes better than pulmonary vascular resistance alone in pediatric patients with pulmonary hypertension","volume":"155","author":"Hunter","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2013.10.028_bib60","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ahj.2011.06.014","article-title":"Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival","volume":"162","author":"Sajan","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2013.10.028_bib61","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/hrt.2010.214130","article-title":"Fractal branching quantifies vascular changes and predicts survival in pulmonary hypertension: a proof of principle study","volume":"97","author":"Moledina","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2013.10.028_bib62","doi-asserted-by":"crossref","first-page":"143428","DOI":"10.1155\/2012\/143428","article-title":"Circulating cytokines and growth factors in pediatric pulmonary hypertension","volume":"2012","author":"Duncan","year":"2012","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jacc.2013.10.028_bib63","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/prca.201100078","article-title":"Plasma proteomics of differential outcome to long-term therapy in children with idiopathic pulmonary arterial hypertension","volume":"6","author":"Yeager","year":"2012","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.jacc.2013.10.028_bib64","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10456-010-9192-y","article-title":"Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension","volume":"14","author":"Smadja","year":"2011","journal-title":"Angiogenesis"},{"key":"10.1016\/j.jacc.2013.10.028_bib65","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1378\/chest.11-0205","article-title":"Circulating myeloid-derived suppressor cells are increased and activated in pulmonary hypertension","volume":"141","author":"Yeager","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2013.10.028_bib66","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1183\/09031936.00072311","article-title":"Circulating fibrocytes are increased in children and young adults with pulmonary hypertension","volume":"39","author":"Yeager","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2013.10.028_bib67","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jped.2012.11.009","article-title":"Persistent pulmonary hypertension of the newborn: recent advances in pathophysiology and treatment","volume":"89","author":"Cabral","year":"2013","journal-title":"J\u00a0Pediatr (Rio J)"},{"key":"10.1016\/j.jacc.2013.10.028_bib68","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.clp.2012.06.006","article-title":"The pulmonary circulation in neonatal respiratory failure","volume":"39","author":"Lakshminrusimha","year":"2012","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.jacc.2013.10.028_bib69","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib70","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/01.CIR.99.9.1197","article-title":"Vasodilator therapy for primary pulmonary hypertension in children","volume":"99","author":"Barst","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.10.028_bib71","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0009-9236(03)00005-5","article-title":"Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension","volume":"73","author":"Barst","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jacc.2013.10.028_bib72","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1365-2125.2009.03532.x","article-title":"Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study","volume":"68","author":"Beghetti","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2013.10.028_bib73","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1203\/PDR.0b013e318179954c","article-title":"Safety experience with bosentan in 146 children 2-11 years old with pulmonary arterial hypertension: results from the European Postmarketing Surveillance Program","volume":"64","author":"Beghetti","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jacc.2013.10.028_bib74","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study","volume":"114","author":"Galie","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.10.028_bib75","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1183\/09031936.00053510","article-title":"Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children","volume":"38","author":"Hislop","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2013.10.028_bib76","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/hrt.2005.072314","article-title":"Response to bosentan in children with pulmonary hypertension","volume":"92","author":"Maiya","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2013.10.028_bib77","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2005.01.066","article-title":"Effects of long-term bosentan in children with pulmonary arterial hypertension","volume":"46","author":"Rosenzweig","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib78","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ppul.22555","article-title":"Clinical safety, pharmacokinetics, and efficacy of ambrisentan therapy in children with pulmonary arterial hypertension","volume":"48","author":"Takatsuki","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jacc.2013.10.028_bib79","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.amjcard.2010.12.051","article-title":"Ambrisentan for pulmonary arterial hypertension due to congenital heart disease","volume":"107","author":"Zuckerman","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib80","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1164\/rccm.201210-1928PP","article-title":"Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension","volume":"187","author":"Abman","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2013.10.028_bib81","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1136\/heart.84.2.e4","article-title":"Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension","volume":"84","author":"Abrams","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2013.10.028_bib82","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.jacc.2009.11.065","article-title":"Pharmacokinetic and hemodynamic responses to oral sildenafil during invasive testing in children with pulmonary hypertension","volume":"55","author":"Apitz","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2013.10.028_bib83","first-page":"979","article-title":"STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive patients with pediatric pulmonary arterial hypertension(abstr)","volume":"33","author":"Barst","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2013.10.028_bib84","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCULATIONAHA.110.016667","article-title":"A\u00a0randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension","volume":"125","author":"Barst","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.10.028_bib85","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S1047951110001745","article-title":"Sildenafil therapy for neonatal and childhood pulmonary hypertensive vascular disease","volume":"21","author":"Humpl","year":"2011","journal-title":"Cardiol Young"},{"key":"10.1016\/j.jacc.2013.10.028_bib86","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1161\/CIRCULATIONAHA.104.473371","article-title":"Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study","volume":"111","author":"Humpl","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.10.028_bib87","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1517\/14656560903413542","article-title":"Tadalafil for the treatment of pulmonary arterial hypertension","volume":"11","author":"Rosenzweig","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jacc.2013.10.028_bib88","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00246-012-0180-4","article-title":"Initial experience with tadalafil in pediatric pulmonary arterial hypertension","volume":"33","author":"Takatsuki","year":"2012","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib89","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijcard.2007.08.084","article-title":"Aerosolized iloprost for postoperative pulmonary hypertensive crisis in children with congenital heart disease","volume":"129","author":"Limsuwan","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib90","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.amjcard.2009.12.075","article-title":"Effectiveness of transition from intravenous epoprostenol to oral\/inhaled targeted pulmonary arterial hypertension therapy in pediatric idiopathic and familial pulmonary arterial hypertension","volume":"105","author":"Melnick","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib91","first-page":"325","article-title":"Review of inhaled iloprost for the control of pulmonary artery hypertension in children","volume":"5","author":"Tissot","year":"2009","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jacc.2013.10.028_bib92","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.amjcard.2012.07.037","article-title":"Effectiveness and safety of inhaled treprostinil for the treatment of pulmonary arterial hypertension in children","volume":"110","author":"Krishnan","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib93","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1086\/605320","article-title":"Closed-hub systems with protected connections and the reduction of risk of catheter-related bloodstream infection in pediatric patients receiving intravenous prostanoid therapy for pulmonary hypertension","volume":"30","author":"Ivy","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib94","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/hrt.2006.096412","article-title":"Epoprostenol treatment in children with severe pulmonary hypertension","volume":"93","author":"Lammers","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2013.10.028_bib95","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/01.CIR.99.14.1858","article-title":"Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects","volume":"99","author":"Rosenzweig","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.10.028_bib96","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.healun.2013.01.1055","article-title":"Children with pulmonary arterial hypertension and prostanoid therapy: long-term hemodynamics","volume":"32","author":"Siehr","year":"2013","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"160","key":"10.1016\/j.jacc.2013.10.028_bib97","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1742-1241.2008.01811.x","article-title":"Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension","author":"Doran","year":"2008","journal-title":"Int J Clin Pract Suppl"},{"key":"10.1016\/j.jacc.2013.10.028_bib98","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jpeds.2010.09.025","article-title":"Add-on therapy with subcutaneous treprostinil for refractory pediatric pulmonary hypertension","volume":"158","author":"Levy","year":"2011","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jacc.2013.10.028_bib99","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0735-1097(98)00238-1","article-title":"Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment","volume":"32","author":"Sandoval","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.10.028_bib100","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.athoracsur.2012.03.099","article-title":"Potts shunt in children with idiopathic pulmonary arterial hypertension: long-term results","volume":"94","author":"Baruteau","year":"2012","journal-title":"Ann Thorac Surg"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109713058713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109713058713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T21:46:08Z","timestamp":1647726368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109713058713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":100,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0735109713058713"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2013.10.028","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}